Literature DB >> 2524441

Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy.

S Julius1, Y Li, D Brant, L Krause, A J Buda.   

Abstract

Repeated neurogenic pressor episodes by hindquarter compression were elicited in nine experimental dogs. Conscious dogs underwent 6 hours of compression every day over a period of 9 weeks. The average mean blood pressure increase during the compression periods was 25 mm Hg, but after decompression the blood pressure promptly returned to baseline values. This blood pressure response was constant and did not change over the 9-week period. The blood pressure increase was associated with a significant increase of plasma norepinephrine values. After validity of the model was established, echocardiographic measurements were performed at baseline and after 3, 6, and 9 weeks of compression in six experimental and six time-control dogs. Concentric left ventricular hypertrophy was already detectable at 3 weeks, and at the ninth week, the left ventricular mass was 28% above the baseline value. The left ventricular mass in time-control dogs remained unchanged over the same period of time. The time-left ventricular mass curves in experimental dogs were significantly different (by profile analysis), had different means (p less than 0.005), were not parallel (p less than 0.0006), and the overall group difference was highly significant (p less than 0.00001). Since left ventricular hypertrophy, a poor prognostic sign in clinical situations, can evolve before established hypertension, present therapeutic recommendations based on permanently elevated blood pressure values may not be entirely justified.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524441     DOI: 10.1161/01.hyp.13.5.422

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Relevance of heart rate as a risk factor in hypertension.

Authors:  P Palatini; S Julius
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

2.  Blood pressure levels and variance assessed by ambulatory monitoring: optimal parameters.

Authors:  F E Yates; L A Benton
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

3.  Cardiovascular reactivity in cardiovascular disease: "once more unto the breach".

Authors:  S B Manuck
Journal:  Int J Behav Med       Date:  1994

Review 4.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

5.  Blood pressure responses to stress: Relation to left ventricular structure and function.

Authors:  A L Hinderliter; K C Light; S S Girdler; P W Willis; A Sherwood
Journal:  Ann Behav Med       Date:  1996-03

Review 6.  Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.

Authors:  P Palatini
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

7.  Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis).

Authors:  Carlos J Rodriguez; Ana V Diez-Roux; Andrew Moran; Zhezhen Jin; Richard A Kronmal; Joao Lima; Shunichi Homma; David A Bluemke; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

8.  Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults.

Authors:  Carlos J Rodriguez; Kirsten Bibbins-Domingo; Zhezhen Jin; Martha L Daviglus; David C Goff; David R Jacobs
Journal:  Hypertension       Date:  2011-07-25       Impact factor: 10.190

Review 9.  Salt intake, blood pressure, and cardiovascular structure.

Authors:  A H Beil; R E Schmieder; F H Messerli
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

10.  Effect of self-initiated and fully-automated self-measurement on blood pressure.

Authors:  Rosanne T Berkhof; Katia Gazzola; Bert-Jan H van den Born
Journal:  J Hum Hypertens       Date:  2019-09-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.